Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹307.00
Market cap: ₹8,675 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.6×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Business Update 3 Annual General Meeting 3 Board Meeting Outcome 2 Promoter Selling (Off-Market) 1 Management Change 1 Fund Raise 1 Financial Results 1 Employee Stock Options 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 Jul 2026 10:12 IST BSE

Employee Stock Options

Suven Life Sciences Employee Stock Options

Suven Life Sciences allotted 271,970 equity shares under its Employee Stock Option Scheme. The shares were admitted for trading on BSE and NSE effective July 3, 2026.

Read the filing ↗